Green arrow that points upwards.
Your privacy is our priority.
By clicking ”accept all“, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts. View our privacy policies for more information.
2.4.2024

medac and XO Life implement cooperation for digital therapy support in uro-oncology

medac and XO Life have developed innovative digital product and therapy support for one of the most important urological medac products.
The medac logo is shown on a wave background

Digital support enables patients to have access to validated medical content during their therapy. They can document their health and treatment history, gain personalized insights and thus actively participate in their healthcare. The systematic recording of the patient's perspective can also be shared with the treating physician. This holistic approach makes a significant contribution to patients' treatment success, adherence and application safety by actively involving experts. Jeanette Holzer, Head of Global Brand Management at medac, emphasizes: “Digital patient support from medac and XO Life is now available and will make a significant contribution to individual health promotion. At medac, we are constantly working to improve patients' quality of life through patient-friendly innovations.” The cooperation impressively demonstrates the commitment of both companies to place patient-centered healthcare at the center of their efforts. Dr. Friderike Bruchmann, CEO of XO Life, comments: “From the outset, XO Life has been committed to digital therapy support. With our platform and important partners such as medac, we can provide better care for more and more patients.” The digital therapy support from medac and XO Life will be available shortly and promises significant progress in the area of individualized health promotion.

Would you like to find out more or are you interested in XO Life?

Get in touch now, get a demo or answer individual questions in a personal conversation.

XO Life News

Discover even more news

image of new brite (formerly impactmonitor) mutaflor treatment space
News
Feb 21, 2025

Ardeypharm and XO Life: brite™ platform enables digital support for Mutaflor®

Mutaflor is the first digital treatment area on the brite™ platform for chronic constipation and bowel inflammation
Read news
image of new brite (formerly impactmonitor) relaunch
News
Jan 28, 2025

XO Life expands internationally - ImpactMonitor™ becomes brite™

XO Life rebrands ImpactMonitor™ to brite™: Digital health platform starts international expansion
Read news
image of impactMonitor for Glenmark
News
Dec 10, 2024

Glenmark launcht eigenen Bereich für Malaria-Prophylaxe und -Therapie auf der ImpactMonitor™-Plattform von XO Life

Glenmark und XO Life bieten Patienten digitalen Support auf der ImpactMonitor™ Plattform an.
Read news

Build meaningful relationships with your patients

Have we sparked your interest or do you have specific questions for us? Let us show you how we can brite up your patients health journey.

I am your personal contact:

Milda Masionyte

Senior Client Partnership Manager